Company: HRTX
Filing Date: 2025-09-09
Form Type: S-3
Source: 0000950170-25-113830
Chunk: 32

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-09-09
Form: S-3
Chunk 32
---
 5,241,410 shares of Common Stock, (ii) all of the shares of Common Stock registered for resale by the registration statement of which this prospectus is a part will be sold and (iii) no other shares of Common Stock will be acquired or sold by the Selling Stockholder before completion of this offering. However, the Selling Stockholder may sell all, part or none of their shares of Common Stock offered pursuant to this prospectus and may sell all, part or none of their Common Stock pursuant to one or more exemptions from the registration provisions of the Securities Act. Applicable percentage ownership after the offering is based on 188,556,077 shares of Common Stock outstanding as of September 3, 2025, after giving effect to 5,241,410 shares of Common Stock issuable upon conversion of all outstanding Series A Convertible Preferred Stock issued pursuant to the Purchase Agreement.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| (3) | The shares reported under “Number of Shares of Common Stock Owned Prior to Offering” consist of (i) 26,608,542 shares of Common Stock held by Rubric Capital Master Fund LP, (ii) 865,080 shares of Common Stock issuable upon the conversion of the Series A Convertible Preferred Stock to Rubric Capital Master Fund LP, (iii) 1,369,480 shares of Common Stock held by Blackstone CSP-MST FMAP Fund, (iv) 44,520 shares of Common Stock issuable upon the conversion of the Series A Convertible Preferred Stock to Blackstone CSP-MST FMAP Fund, (v) 1,122,706 shares of Common Stock held by BEMAP Master Fund Ltd., (vi) 36,500 shares of Common Stock issuable upon the conversion of the Series A Convertible Preferred Stock to BEMAP Master Fund Ltd. and (vii) 19,444,444 shares of Common Stock issuable upon the conversion of the Notes issued to Rubric Long Term Opportunities Offshore Master Fund LP pursuant to the Note Purchase Agreement. Rubric Capital Master Fund LP, Blackstone CSP-MST FMAP Fund, BEMAP Master Fund Ltd. and Rubric Long Term Opportunities Offshore Master Fund LP are collectively referred to herein as the “Rubric Funds.” Each of Blackstone CSP-MST FMAP Fund, BEMAP Master Fund Ltd. and Rubric Long Term Opportunities Offshore Master Fund LP is managed or sub-managed by Rubric Capital Management LP, as applicable. The